• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PERCIVA ICD VR; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PERCIVA ICD VR; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number D400
Medical Device Problem Codes High impedance (1291); Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Codes Electric Shock (2554); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/14/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that this implantable cardioverter defibrillator (icd) recorded a code 1005, indicative of shocking into an open circuit.This device also recorded high out of range shocking impedance values.Technical services (ts) recommended further review and possible replacement of the associated right ventricular (rv) lead.Information from the field suggested that the physician discussed system replacement with the patient, however they chose to leave the emergency room (er) against medical advice.This device remains in service.No adverse patient effects were reported.
 
Event or Problem Description
It was reported that this implantable cardioverter defibrillator (icd) recorded a code 1005, indicative of shocking into an open circuit.This device also recorded high out of range shocking impedance values.Technical services (ts) recommended further review and possible replacement of the associated right ventricular (rv) lead.Information from the field suggested that the physician discussed system replacement with the patient, however they chose to leave the emergency room (er) against medical advice.This device remains in service.No adverse patient effects were reported.It was subsequently reported that this device delivered appropriate therapy and that the impedance on the therapy was high and out of range.It was further reported that commanded shocks had been performed and that the impedance results were lower than with the delivered therapy.Technical services (ts) could not establish a reason for the in-range shock impedances, as no apparent changes had been made to the device programming.Continued monitoring by the physician was planned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCIVA ICD VR
Common Device Name
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key17850805
Report Number2124215-2023-53939
Device Sequence Number3389936
Product Code LWS
UDI-Device Identifier00802526587863
UDI-Public00802526587863
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 11/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date10/04/2024
Device Model NumberD400
Device Catalogue NumberD400
Device Lot Number114406
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 09/11/2023
Supplement Date Received by Manufacturer11/10/2023
Initial Report FDA Received Date10/02/2023
Supplement Report FDA Received Date11/24/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured10/12/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age68 YR
Patient SexMale
-
-